title: Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
abstract: HIV-associated neurocognitive disorders (HAND) affect up to 50 % of HIV-infected adults, independently predict HIV morbidity/mortality, and are associated with neuronal damage and monocyte activation. Cerebrospinal fluid (CSF) neurofilament subunits (NFL, pNFH) are sensitive surrogate markers of neuronal damage in several neurodegenerative diseases. In HIV, CSF NFL is elevated in individuals with and without cognitive impairment, suggesting early/persistent neuronal injury during HIV infection. Although individuals with severe cognitive impairment (HIV-associated dementia (HAD)) express higher CSF NFL levels than cognitively normal HIV-infected individuals, the relationships between severity of cognitive impairment, monocyte activation, neurofilament expression, and systemic infection are unclear. We performed a retrospective cross-sectional study of 48 HIV-infected adults with varying levels of cognitive impairment, not receiving antiretroviral therapy (ART), enrolled in the CNS Anti-Retroviral Therapy Effects Research (CHARTER) study. We quantified NFL, pNFH, and monocyte activation markers (sCD14/sCD163) in paired CSF/plasma samples. By examining subjects off ART, these correlations are not confounded by possible effects of ART on inflammation and neurodegeneration. We found that CSF NFL levels were elevated in individuals with HAD compared to cognitively normal or mildly impaired individuals with CD4+ T-lymphocyte nadirs ≤200. In addition, CSF NFL levels were significantly positively correlated to plasma HIV-1 RNA viral load and negatively correlated to plasma CD4+ T-lymphocyte count, suggesting a link between neuronal injury and systemic HIV infection. Finally, CSF NFL was significantly positively correlated with CSF pNFH, sCD163, and sCD14, demonstrating that monocyte activation within the CNS compartment is directly associated with neuronal injury at all stages of HAND.
authors.affiliation: Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA, mcguirej@email.chop.edu.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: McGuire
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Gill
authors.forename: Steven D
authors.initials: SD
authors.lastname: Douglas
authors.forename: Dennis L
authors.initials: DL
authors.lastname: Kolson
mesh_terms: D015526:AIDS Dementia Complex / Q000134:cerebrospinal fluid* / Q000276:immunology* / Q000473:pathology*; D000328:Adult; D015415:Biomarkers / Q000032:analysis*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008262:Macrophage Activation; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology; D009410:Nerve Degeneration / Q000821:virology; D016900:Neurofilament Proteins / Q000134:cerebrospinal fluid; D009483:Neuropsychological Tests; D012189:Retrospective Studies
chemical_list: D015415:Biomarkers; D016900:Neurofilament Proteins